Martin Scanlon

Finished

New Biomolecular Capabilities for the Melbourne Magnetic Resonance Facility

Gooley, P., Scanlon, M., Mackay, J. P., Jones, O. A. H., Komander, D., McDevitt, C. A., Urban, S., Maher, M. J., Griffin, M. D. W., Call, M. E., Borg, N., Leach, K., Gregory, K. & Babon, J.

7/05/21 → 6/05/22

Project: Research

Using fragment-based drug discovery to identify small molecule inhibitors of SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase (RdRp) and future starting points for other Coronaviruses

Angell, R. & Scanlon, M.

20/10/20 → 19/10/21

Project: Research

Identification of Inhibitors of a key oncogenic protein by Fragment Screening

Scanlon, M. & Dymock, B.

4/03/20 → 3/03/21

Project: Research

IC18.8 Characterisation of soluble and membrane proteins for fragment-based screening using mass spectrometry

Poulsen, S., Scanlon, M., Hallili, M. & Capuano, B.

22/07/19 → 21/07/21

Project: Research

Neisserial DsbD inhibitor program

Scanlon, M.

5/12/18 → 4/12/19

Project: Research

Intracellular Drug Transport

Porter, C., Scanlon, M. & Halls, M.

26/04/18 → 26/04/20

Project: Research

Compounds Australia - Enabling the Next Phase of Australian Drug Discovery

Poulsen, S., Martin, J. L., Avery, V. M., Quinn, R. J., Baell, J., Scanlon, M., Booker, G. W., Abell, A., Wang, S., Karuso, P., Guillemin, G. A., Smith, J. A., Ryan, J. H. & Peat, T. S.

Monash University – Internal University Contribution, Monash University – Internal School Contribution

10/03/17 → 9/03/18

Project: Research

Fragment-based design of inhibitors of the essential Neisserial enzyme DsbD

Scanlon, M., Devine, S., Heras, B. & Kahler, C.

British Society for Antimicrobial Chemotherapy

16/05/16 → 31/12/17

Project: Research

Discovery of selective ligands of certain kinases as development candidates for radiolabeled diagnostics for use in multiple sclerosis

Baell, J., Binder, M., Field, J., Kilpatrick, T. J., Scanlon, M. & Xiao, J.

University of Melbourne

1/01/16 → 31/12/16

Project: Research

Distributed facility for fragment based drug discovery

Scanlon, M., Dixon, N., Gooley, P., Hughes, R. A., Kwan, A., Lewis, P., Mackay, J., Matthews, J., Norton, R., Oakley, A. J. & Scammells, P.

Australian Research Council (ARC), Monash University, University of Sydney, University of Wollongong, University of Newcastle, University of Melbourne

1/01/16 → 27/09/16

Project: Research

Are chemokines druggable? Targeting monocyte chemoattractant protein-1 (MCP-1) by fragment-based drug discovery

Stone, M., Scanlon, M., Canals, M. & Harper, B.

Monash University – Internal Faculty Contribution

1/01/16 → 24/12/17

Project: Research

DsbA inhibitors: from hits to leads

Martin, J. L., Scanlon, M., Heras, B., Scammells, P. & Torsika, M.

1/01/16 → 31/12/18

Project: Research

Anti-Malarial Agents Targeting Apical Membrane Antigen 1

Norton, R., McGowan, S., Scammells, P. & Scanlon, M.

National Health and Medical Research Council (NHMRC) (Australia)

1/01/16 → 31/12/18

Project: Research

NHMRC Equipment Grant - BiaCore S200 (Molecular Interaction Analysis System using Surface Plasmon Resonance (SPR) Spectroscopy

Scanlon, M., Bunnett, N., Headey, S., Norton, R. & Thompson, P.

National Health and Medical Research Council (NHMRC) (Australia)

1/12/15 → 31/12/15

Project: Research

New inhibitors for HIV

Jans, D., Baell, J., Scanlon, M., Tachedjian, G. & Wagstaff, K.

Australian Centre for HIV and Hepatitis Virology Research

1/01/15 → 30/06/16

Project: Research

LptA: Structure-based design of novel therapeutics for multi-drug resistant Neisseria gonorrhoeae

Vrielink, A., Stubbs, K., Scanlon, M. & Kahler, C.

1/01/15 → 31/12/17

Project: Other

Understanding the Cellular Pathways of Nuclear Receptor Activation

Porter, C., Bunnett, N., Halls, M. & Scanlon, M.

Australian Research Council (ARC), Monash University

1/01/15 → 31/12/19

Project: Research

Inhibition of oxidative protein folding in Neisseria

Scanlon, M., Heras, B., Iannello, R. & Morton, C. J.

Monash University

1/01/14 → 31/12/14

Project: Research

Towards medicines for melioidosis, a naturally drug-resistant infectious disease endemic in northern Australia

Martin, J. L., Scanlon, M., Sarkar-Tyson, M. & Currie, B. J.

National Health and Medical Research Council (NHMRC) (Australia)

1/01/14 → 31/12/16

Project: Research

Direct Detect Spectrometer and Starter Kit

Norton, R., Scanlon, M. & Thompson, P.

Collier Charitable Fund

1/01/13 → 30/09/13

Project: Research

Structure-based design of inhibitors of PimA - a new target for tuberculosis therapy

Scanlon, M., Coppel, R., Simpson, J., Chalmers, D., Crellin, P. & Stubbs, K.

National Health and Medical Research Council (NHMRC) (Australia)

1/01/13 → 31/12/16

Project: Research

Intracellular lipid binding proteins as gatekeepers of drug activity

Porter, C., Bunnett, N. & Scanlon, M.

Australian Research Council (ARC), Monash University

3/01/12 → 31/12/14

Project: Research

Inhibitors of Inducible Nitric Oxide Synthase (iNOS) Regulation as a Basis for Novel Anti-Infective Agents

Norton, R., Scanlon, M. & Baell, J.

National Health and Medical Research Council (NHMRC) (Australia)

1/01/12 → 31/12/14

Project: Research

A 700 MHz NMR Spectrometer for the Melbourne Biomolecular NMR Network: A High Throughput Resource

Scanlon, M., Babon, J. J., Bottomley, S., Call, M., Gooley, P., Gras, S., Hinds, M. G., McConville, M., Norton, R., Reynolds, E. C., Separovic, F. & Stone, M.

Australian Research Council (ARC)

1/01/12 → 31/12/12

Project: Research